Dr RR Baliga's "Got Knowledge Doc" Podkast

🚨 New in Nature 🧬: Groundbreaking study reveals how HMGN1, a dosage-sensitive epigenetic regulator on chromosome 21, reprograms atrioventricular cardiomyocytes into a ventricular fate—driving congenital heart defects in Down syndrome 💔🫀.

Using hiPSCs, single-cell RNA sequencing, and a CRISPRa CROP-seq screen, researchers pinpoint HMGN1 as a causal gene. Strikingly, reducing its dosage in a trisomy 21 mouse model reversed ventricular septal defects (VSDs) 🔧🐭.

This is a model for dissecting aneuploidy-associated disease using human cells + in vivo rescue. Epigenetics meets cardiogenesis in real time. Don't miss this paradigm-shifting work!

📖 DOI: 10.1038/s41586-025-09593-9

#DownSyndrome #Cardiology #Epigenetics #CRISPR #scRNAseq #HMGN1 #CongenitalHeartDefects #StemCells #Nature #GeneDosage #PrecisionMedicine

🚭 Lung Cancer in Nonsmokers – a hidden epidemic affecting up to 20% of global cases 🌍. Unlike tobacco-related disease, this form often strikes younger, female, and Asian populations, with EGFR and ALK mutations driving tumors 🔬.

Despite low mutation burden and no smoking history, these patients benefit immensely from targeted therapies like osimertinib and lorlatinib 🎯. Yet, there's no USPSTF recommendation for screening in this group 😔.

We must push for awareness, early detection, and precision approaches 🧬. As the review in JAMA (2025) shows, no smoke doesn't mean no risk.

🔗 doi:10.1001/jama.2025.17695

#LungCancer #PrecisionMedicine #Oncology #PublicHealth #JAMA

👟 Just 2 Days Can Make a Difference! 🧓📉

In a large cohort of 13,547 older women (mean age 72), walking ≥4,000 steps/day on even 1–2 days/week was linked to a 26% lower mortality and 27% lower cardiovascular disease risk 💥. Those walking ≥3 days/week had even greater benefits!

📉 Higher step thresholds (up to 7,000/day) showed further mortality reduction—but step volume, not frequency, drove outcomes.

🧠 Message? There's no "perfect pattern"—even weekend walks count.

💡 Time to rethink activity guidelines and empower aging with steps.

📄 Hamaya R et al, Br J Sports Med, 2025.

🔗 https://doi.org/10.1136/bjsports-2025-110311 #Longevity #CardioHealth #WomenInMedicine #PublicHealth #WeekendWarrior #HealthyAging #ExactitudeStudy #StepsToHealth #CVD #ExerciseIsMedicine

🧓 Aging skin, fading flow. This 2025 Nature study uncovers how dermal capillary-associated macrophages (CAMs) decline with age—preceding microvascular dysfunction and impaired blood flow.

🧬 Using intravital imaging and macrophage fate mapping in mice (and validating in humans!), the authors reveal that CAMs are not replenished unless triggered by injury or CSF1. 🛠️ Fascinatingly, local CSF1–Fc therapy restored CAMs and rejuvenated perfusion in aged skin. A compelling case for targeting tissue-resident immunity! 🩸

📖 doi:10.1038/s41586-025-09639-y

🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs.

👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3

#SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet

Hair Loss in Women" (The New England Journal of Medicine 2025; DOI 10.1056/NEJMcp2412146) 📄, and it's a must‑listen for anyone in clinical practice or research.

The piece highlights that female‑pattern hair loss increases with age and is closely tied to hormonal status, and that treatments span from topical 5% minoxidil or low‑dose oral minoxidil to anti‑androgens and adjunctive non‑drug approaches.

🔍 New in The Lancet! A massive network meta-analysis of 94 RCTs (105,435 patients) reveals that antidepressants impact far more than mood 🧠—they alter weight ⚖️, glucose 🩸, BP 💓, lipids 🧬, and liver enzymes 🧪.

Agomelatine 🌙 may lower weight, while nortriptyline 📈 raises heart rate. Time to rethink side-effect profiles when prescribing!

📚 Pills, Pressure, and Physiology — catch the full summary & clinical pearls now!

#Antidepressants #CardiometabolicHealth #Depression #PrecisionMedicine #Lancet 🧠💊⚖️

🧬 Her Genes, His Risk, Our Mind 💡

New insights from Thomas et al., Nature Communications (2025) — summarized beautifully by Na Cai in Nature News & Views. Women carry a heavier polygenic burden for major depressive disorder (MDD), with ~6,000 female-specific variants and stronger genetic links to metabolic traits like BMI and metabolic syndrome. 🧠

Men show a unique X-chromosome signal (IL1RAPL1), pointing to sex-specific biology in depression. Precision psychiatry must evolve to be sex-aware, data-driven, and equitable. ⚕️

#Genomics #Depression #PrecisionMedicine #SexDifferences #Neurogenetics

🦷🫀 New Findings Linking Oral Health to Heart Attacks! 🧬🧫

Groundbreaking research in JAHA reveals that viridans streptococci, common oral bacteria, form biofilms in atherosclerotic plaques that evade immune detection.

These stealthy invaders trigger innate and adaptive immune responses, correlating with plaque rupture, myocardial infarction, and sudden cardiac death.

The study combines autopsy data, endarterectomy samples, immunohistochemistry, TLR activation assays, and genome-wide expression to uncover this bacterial-inflammation nexus.

🧠 Could dental hygiene be the next frontier in cardiovascular prevention?

📖 Karhunen et al. JAHA. 2025;14:e041521

🔗 #Cardiology #Immunology #OralHealth #Atherosclerosis #Biofilm #PrecisionMedicine #JAHA #DentalHealth #SuddenCardiacDeath #MultiOmics #CHD #ViridansStreptococci #PlaqueRupture #InnateImmunity #AdaptiveImmunity #TLR2 #NFkB #Streptococcus #MI #Endarterectomy

🧠 Why Does Alzheimer's Affect More Women Than Men?

New insights from JAMA Medical News reveal that the answer goes far beyond longevity. 🌸

Biology, hormones, and even social factors intertwine — from estrogen decline and X chromosome genetics to APOE4 risks and underdiagnosis due to stronger verbal memory.

Women make up two-thirds of all Alzheimer's cases, yet most clinical trials overlook sex-based analyses. As researchers call for more inclusive designs, one thing is clear — understanding how biology and bias intersect is vital for progress. 💡

🔬 It's time for Alzheimer's research to think beyond averages — and start thinking in X and Y.

#AlzheimersDisease #WomensHealth #Neuroscience #PrecisionMedicine #JAMA #SexDifferences #Neurodegeneration